Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer through effective PI3Kinase targeting

Pedram Yadollahi(Baylor College of Medicine), Vlad C. Sandulache(Michael E. DeBakey VA Medical Center)
British Journal of Cancer
October 6, 2025
Cited by 0


Related Papers